Anna Kuisma

652 total citations
11 papers, 489 citations indexed

About

Anna Kuisma is a scholar working on Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Oncology. According to data from OpenAlex, Anna Kuisma has authored 11 papers receiving a total of 489 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pulmonary and Respiratory Medicine, 8 papers in Radiology, Nuclear Medicine and Imaging and 3 papers in Oncology. Recurrent topics in Anna Kuisma's work include Prostate Cancer Treatment and Research (7 papers), Radiopharmaceutical Chemistry and Applications (5 papers) and Medical Imaging Techniques and Applications (5 papers). Anna Kuisma is often cited by papers focused on Prostate Cancer Treatment and Research (7 papers), Radiopharmaceutical Chemistry and Applications (5 papers) and Medical Imaging Techniques and Applications (5 papers). Anna Kuisma collaborates with scholars based in Finland, United States and Germany. Anna Kuisma's co-authors include Ivan Jambor, Jukka Kemppainen, Heikki Minn, Sami Kajander, Marko Seppänen, Tommi Noponen, Harri Merisaari, Hannu J. Aronen, Esa Kähkönen and Tuula Tolvanen and has published in prestigious journals such as Scientific Reports, Clinical Cancer Research and Annals of Oncology.

In The Last Decade

Anna Kuisma

11 papers receiving 484 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna Kuisma Finland 8 338 288 156 47 42 11 489
Esa Kähkönen Finland 11 267 0.8× 360 1.3× 178 1.1× 78 1.7× 35 0.8× 17 531
Gianpaolo di Santo Italy 10 263 0.8× 358 1.2× 92 0.6× 64 1.4× 76 1.8× 24 499
Reyhaneh Manafi‐Farid Iran 12 208 0.6× 175 0.6× 118 0.8× 21 0.4× 37 0.9× 25 339
C. Stoykow Germany 11 188 0.6× 103 0.4× 132 0.8× 76 1.6× 24 0.6× 14 353
Jonathan Kuten Israel 12 194 0.6× 252 0.9× 149 1.0× 20 0.4× 91 2.2× 23 419
Martijn B. Busstra Netherlands 13 126 0.4× 316 1.1× 124 0.8× 42 0.9× 38 0.9× 32 493
Maythinee Chantadisai Thailand 9 205 0.6× 92 0.3× 229 1.5× 45 1.0× 64 1.5× 20 391
Sofia C. Vaz Portugal 12 245 0.7× 176 0.6× 95 0.6× 31 0.7× 68 1.6× 36 429
Ghasemali Divband Iran 10 167 0.5× 75 0.3× 230 1.5× 38 0.8× 69 1.6× 32 328
Niklaus Schäfer Switzerland 8 145 0.4× 127 0.4× 153 1.0× 128 2.7× 24 0.6× 11 355

Countries citing papers authored by Anna Kuisma

Since Specialization
Citations

This map shows the geographic impact of Anna Kuisma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Kuisma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Kuisma more than expected).

Fields of papers citing papers by Anna Kuisma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Kuisma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Kuisma. The network helps show where Anna Kuisma may publish in the future.

Co-authorship network of co-authors of Anna Kuisma

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Kuisma. A scholar is included among the top collaborators of Anna Kuisma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Kuisma. Anna Kuisma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Malaspina, Simona, Pekka Taimen, Markku Kallajoki, et al.. (2021). Uptake of 18 F-rhPSMA-7.3 in Positron Emission Tomography Imaging of Prostate Cancer: A Phase 1 Proof-of-Concept Study. Cancer Biotherapy and Radiopharmaceuticals. 37(3). 205–213. 6 indexed citations
2.
Malaspina, Simona, Vesa Oikonen, Anna Kuisma, et al.. (2021). Kinetic analysis and optimisation of 18F-rhPSMA-7.3 PET imaging of prostate cancer. European Journal of Nuclear Medicine and Molecular Imaging. 48(11). 3723–3731. 11 indexed citations
3.
Tolvanen, Tuula, Kari K. Kalliokoski, Simona Malaspina, et al.. (2020). Safety, Biodistribution, and Radiation Dosimetry of 18F-rhPSMA-7.3 in Healthy Adult Volunteers. Journal of Nuclear Medicine. 62(5). 679–684. 27 indexed citations
4.
Kuisma, Anna, Jani Keyriläinen, Sami Suilamo, et al.. (2020). Validation of automated magnetic resonance image segmentation for radiation therapy planning in prostate cancer. Physics and Imaging in Radiation Oncology. 13. 14–20. 12 indexed citations
5.
Movahedi, Parisa, Harri Merisaari, Ileana Montoya Perez, et al.. (2020). Prediction of prostate cancer aggressiveness using 18F-Fluciclovine (FACBC) PET and multisequence multiparametric MRI. Scientific Reports. 10(1). 4 indexed citations
6.
7.
Jambor, Ivan, Anna Kuisma, Jukka Kemppainen, et al.. (2019). Comparison of standardized uptake values between 99mTc-HDP SPECT/CT and 18F-NaF PET/CT in bone metastases of breast and prostate cancer. EJNMMI Research. 9(1). 6–6. 48 indexed citations
8.
Jambor, Ivan, Anna Kuisma, Esa Kähkönen, et al.. (2017). Prospective evaluation of 18F-FACBC PET/CT and PET/MRI versus multiparametric MRI in intermediate- to high-risk prostate cancer patients (FLUCIPRO trial). European Journal of Nuclear Medicine and Molecular Imaging. 45(3). 355–364. 56 indexed citations
9.
10.
Kähkönen, Esa, Ivan Jambor, Jukka Kemppainen, et al.. (2013). In Vivo Imaging of Prostate Cancer Using [68Ga]-Labeled Bombesin Analog BAY86-7548. Clinical Cancer Research. 19(19). 5434–5443. 162 indexed citations
11.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Esa Kähkönen Breakdown of academic impact, for papers by Gianpaolo di Santo Breakdown of academic impact, for papers by Reyhaneh Manafi‐Farid Breakdown of academic impact, for papers by C. Stoykow Breakdown of academic impact, for papers by Jonathan Kuten Breakdown of academic impact, for papers by Martijn B. Busstra Breakdown of academic impact, for papers by Maythinee Chantadisai Breakdown of academic impact, for papers by Sofia C. Vaz Breakdown of academic impact, for papers by Ghasemali Divband Breakdown of academic impact, for papers by Niklaus Schäfer
Rankless by CCL
2026